Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors
Transfusion · 2026
DOI: 10.1111/trf.70103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Sofiane Driouche und 15 weiteren Autor:innen. Beteiligte Einrichtung: Établissement Français du Sang, Île-de-France Mondor, Créteil, France. Hauptthemen laut MEDLINE: Carbon Monoxide, Erythrocytes, Sickle Cell Trait, Blood Preservation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
Filtration failures in sickle cell trait (SCT, AS) blood donations limit the availability of antigen‐matched red blood cell concentrates (RBCCs) for transfusion. Carbon monoxide (CO), by stabilizing hemoglobin in its high‐affinity relaxed state, may prevent filter clogging and restore leukofiltration efficiency. However, the storage quality and stability of CO‐treated RBCCs remain to be evaluated. Study Design and Methods RBCCs from normal (AA) donors and AS donors with prior leukofiltration failure were categorized as AA‐NC (untreated AA), AA‐CO (CO‐treated AA), and AS‐CO (CO‐treated AS). CO treatment consisted of exposing RBCCs to CO gas under controlled conditions before leukofiltration. Filtration success, hematological parameters, metabolic stability, oxidative stress markers, and hemolysis parameters were analyzed on days 0, 14, 28, and 42.
Results
CO treatment reversed filter clogging in AS RBCCs, enabling successful leukofiltration without significant hemolysis. It induced approximately 90% COHb, with a slight increase in MetHb due to the injection technique, which remained stable throughout the 42‐day storage period. Hematological and metabolic parameters were preserved across groups. CO also reduced free Hb oxidation in both AA and AS RBCCs and limited storage lesions in AA RBCCs, whereas AS RBCs remained more prone to senescence at the end of storage.
Discussion
CO treatment enables successful leukofiltration of previously non‐filterable AS RBCCs and helps preserve RBC quality during storage. This strategy could enhance the availability of antigen‐matched RBCCs and improve transfusion safety in sickle cell disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Établissement Français du Sang, Île-de-France Mondor, Créteil, France.
- Laboratoire d'Excellence, INSERM U955, IMRB, Team Pirenne, Créteil, France.
- Department of Biochemistry and Molecular Biology, Henri Mondor University Hospital, Créteil, France.
- Etablissement Français du Sang, Rungis, France.
- Unité de Recherche Clinique, Henri-Mondor University Hospital-UPEC, AP-HP, Creteil, France.
- Centre de référence des syndromes drépanocytaires majeurs, Hôpital Henri-Mondor, AP-HP, Créteil, France.
ORCID-Profile: Kim-Anh Nguyen
Zitieren
APA
Driouche, S., Kiger, L., Moutereau, S., Mouri, N., Drémont, K., Cléophax, S., Bencheikh, L., de Pierrefeu, V. M. D., Tristan, R., Adu, E., Pakdaman, S., Bartolucci, P., Baudin-Creuza, V., Pirenne, F., Beuzard, Y., & Nguyen, K. A. (2026). Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors. Transfusion. https://doi.org/10.1111/trf.70103
Vancouver
Driouche S, Kiger L, Moutereau S, Mouri N, Drémont K, Cléophax S, et al. Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors. Transfusion. 2026. doi:10.1111/trf.70103
BibTeX
@article{Driouche2026,
author = {Driouche, Sofiane and Kiger, Laurent and Moutereau, Stephane and Mouri, Nadir and Drémont, Katy and Cléophax, Sabine and Bencheikh, Laura and de Pierrefeu, Vincent Malcor Deydier and Tristan, Remy and Adu, Emmanuel and Pakdaman, Sadaf and Bartolucci, Pablo and Baudin-Creuza, Véronique and Pirenne, France and Beuzard, Yves and Nguyen, Kim-Anh},
title = {Carbon monoxide treatment rescues leukofiltration and preserves storage quality of red blood cell concentrates from sickle cell trait donors},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70103}
}
EUVIMED